Gregory S. Brigham

3.0k total citations
41 papers, 2.0k citations indexed

About

Gregory S. Brigham is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and General Health Professions. According to data from OpenAlex, Gregory S. Brigham has authored 41 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Epidemiology, 14 papers in Public Health, Environmental and Occupational Health and 9 papers in General Health Professions. Recurrent topics in Gregory S. Brigham's work include Substance Abuse Treatment and Outcomes (23 papers), Opioid Use Disorder Treatment (12 papers) and Prenatal Substance Exposure Effects (8 papers). Gregory S. Brigham is often cited by papers focused on Substance Abuse Treatment and Outcomes (23 papers), Opioid Use Disorder Treatment (12 papers) and Prenatal Substance Exposure Effects (8 papers). Gregory S. Brigham collaborates with scholars based in United States, Austria and India. Gregory S. Brigham's co-authors include Jeffrey Selzer, James L. Sorensen, William R. Miller, Theresa Winhusen, Eugene Somoza, Edward V. Nunes, Natasha Slesnick, Daniel Lewis, Denise A. Hien and Aimee Campbell and has published in prestigious journals such as American Journal of Psychiatry, Journal of Consulting and Clinical Psychology and Addiction.

In The Last Decade

Gregory S. Brigham

41 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gregory S. Brigham United States	23	845	617	537	497	236	41	2.0k
Alex Baldacchino United Kingdom	25	625 0.7×	651 1.1×	530 1.0×	390 0.8×	293 1.2×	111	2.2k
Rachel Humeniuk Australia	16	1.1k 1.3×	493 0.8×	475 0.9×	630 1.3×	206 0.9×	30	2.2k
Jessica M. Peirce United States	22	837 1.0×	491 0.8×	436 0.8×	281 0.6×	234 1.0×	49	1.5k
Michael Kidorf United States	32	1.5k 1.7×	992 1.6×	505 0.9×	355 0.7×	355 1.5×	84	2.3k
Ron A. Cisler United States	22	1.6k 2.0×	449 0.7×	472 0.9×	538 1.1×	251 1.1×	59	2.8k
David S. Festinger United States	28	1.3k 1.6×	749 1.2×	768 1.4×	587 1.2×	271 1.1×	73	2.3k
Victoria Manning Australia	31	1.2k 1.5×	593 1.0×	818 1.5×	765 1.5×	349 1.5×	158	2.8k
Victoria R. Votaw United States	18	683 0.8×	401 0.6×	466 0.9×	224 0.5×	172 0.7×	51	1.8k
Iván D. Montoya United States	30	1.0k 1.2×	662 1.1×	571 1.1×	375 0.8×	463 2.0×	71	2.5k
Conrad J. Wong United States	27	1.2k 1.4×	431 0.7×	399 0.7×	485 1.0×	314 1.3×	54	2.2k

Countries citing papers authored by Gregory S. Brigham

Since Specialization

Citations

This map shows the geographic impact of Gregory S. Brigham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory S. Brigham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory S. Brigham more than expected).

Fields of papers citing papers by Gregory S. Brigham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory S. Brigham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory S. Brigham. The network helps show where Gregory S. Brigham may publish in the future.

Co-authorship network of co-authors of Gregory S. Brigham

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory S. Brigham. A scholar is included among the top collaborators of Gregory S. Brigham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory S. Brigham. Gregory S. Brigham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Joshua D., Edward V. Nunes, Patricia Novo, et al.. (2016). NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationale. Contemporary Clinical Trials. 50. 253–264. 49 indexed citations

Slesnick, Natasha, et al.. (2014). Parenting under the influence: The effects of opioids, alcohol and cocaine on mother–child interaction. Addictive Behaviors. 39(5). 897–900. 41 indexed citations

Wells, Elizabeth A., Dennis M. Donovan, Dennis C. Daley, et al.. (2014). Is level of exposure to a 12-step facilitation therapy associated with treatment outcome?. Journal of Substance Abuse Treatment. 47(4). 265–274. 7 indexed citations

Winhusen, Theresa, Daniel Lewis, Bryon Adinoff, et al.. (2013). Impulsivity is associated with treatment non-completion in cocaine- and methamphetamine-dependent patients but differs in nature as a function of stimulant-dependence diagnosis. Journal of Substance Abuse Treatment. 44(5). 541–547. 44 indexed citations

Winhusen, Theresa, Bryon Adinoff, Daniel Lewis, et al.. (2013). A tale of two stimulants: Mentholated cigarettes may play a role in cocaine, but not methamphetamine, dependence. Drug and Alcohol Dependence. 133(3). 845–851. 13 indexed citations

Winhusen, Theresa, Kathleen T. Brady, Maxine L. Stitzer, et al.. (2012). Evaluation of buspirone for relapse-prevention in adults with cocaine dependence: An efficacy trial conducted in the real world. Contemporary Clinical Trials. 33(5). 993–1002. 14 indexed citations

Winhusen, Theresa, Maxine L. Stitzer, George Woody, et al.. (2011). Design considerations for a study to evaluate the impact of smoking cessation treatment on stimulant use outcomes in stimulant-dependent individuals. Contemporary Clinical Trials. 33(1). 197–205. 13 indexed citations

Donovan, Dennis M., George E. Bigelow, Gregory S. Brigham, et al.. (2011). Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end‐points in clinical trials. Addiction. 107(4). 694–708. 150 indexed citations

Nunes, Edward V., Samuel A. Ball, Robert E. Booth, et al.. (2010). Multisite effectiveness trials of treatments for substance abuse and co-occurring problems: Have we chosen the best designs?. Journal of Substance Abuse Treatment. 38. S97–S112. 20 indexed citations

10.

Winhusen, Theresa, Eugene Somoza, Gregory S. Brigham, et al.. (2010). Impact of Attention-Deficit/Hyperactivity Disorder (ADHD) Treatment on Smoking Cessation Intervention in ADHD Smokers. The Journal of Clinical Psychiatry. 71(12). 1680–1688. 73 indexed citations

11.

Martino, Steve, Gregory S. Brigham, Thomas E. Freese, et al.. (2010). Partnerships and pathways of dissemination: The National Institute on Drug Abuse—Substance Abuse and Mental Health Services Administration Blending Initiative in the Clinical Trials Network. Journal of Substance Abuse Treatment. 38. S31–S43. 41 indexed citations

12.

Ling, Walter, Petra Jacobs, Maureen Hillhouse, et al.. (2010). From research to the real world: Buprenorphine in the decade of the Clinical Trials Network. Journal of Substance Abuse Treatment. 38. S53–S60. 37 indexed citations

13.

Brigham, Gregory S., Theresa Winhusen, Daniel Lewis, & Frankie Kropp. (2009). Incentives for retention of pregnant substance users: A secondary analysis. Journal of Substance Abuse Treatment. 38(1). 90–95. 16 indexed citations

14.

Hien, Denise A., Huiping Jiang, Aimee Campbell, et al.. (2009). Do Treatment Improvements in PTSD Severity Affect Substance Use Outcomes? A Secondary Analysis From a Randomized Clinical Trial in NIDA's Clinical Trials Network. American Journal of Psychiatry. 167(1). 95–101. 237 indexed citations

15.

Robbins, Michael S., José Szapocznik, Viviana E. Horigian, et al.. (2009). Brief strategic family therapy™ for adolescent drug abusers: A multi-site effectiveness study. Contemporary Clinical Trials. 30(3). 269–278. 27 indexed citations

16.

Brigham, Gregory S., Daniel J. Feaster, Paul Wakim, & Catherine L. Dempsey. (2009). Choosing a control group in effectiveness trials of behavioral drug abuse treatments. Journal of Substance Abuse Treatment. 37(4). 388–397. 28 indexed citations

17.

Killeen, Therese K., Denise A. Hien, Aimee Campbell, et al.. (2008). Adverse events in an integrated trauma-focused intervention for women in community substance abuse treatment. Journal of Substance Abuse Treatment. 35(3). 304–311. 33 indexed citations

18.

Brigham, Gregory S., et al.. (2007). Addressing Smoking in Community Drug Abuse Treatment Programs: Practical and Policy Considerations. Journal of Psychoactive Drugs. 39(4). 435–441. 7 indexed citations

19.

Miller, William R., James L. Sorensen, Jeffrey Selzer, & Gregory S. Brigham. (2006). Disseminating evidence-based practices in substance abuse treatment: A review with suggestions. Journal of Substance Abuse Treatment. 31(1). 25–39. 312 indexed citations

20.

Amass, Leslie, Walter Ling, Thomas E. Freese, et al.. (2004). Bringing Buprenorphine‐Naloxone Detoxification to Community Treatment Providers: The NIDA Clinical Trials Network Field Experience. American Journal on Addictions. 13(S1). S42–66. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact